Title: Stauffer’s Syndrome: A Rare Case Report
Authors: Dr Himesh Gandhi, Dr Bhondave S.T., Dr Manoj Shrivastav, Dr Aman Gupta, Dr Tarun Singh
DOI: https://dx.doi.org/10.18535/jmscr/v9i3.02
Abstract
Background: Stauffer’s syndrome is non- metastatic liver dysfunction in patients suffering from renal cell carcinoma (RCC). It is one of the rare variant of paraneoplastic syndrome associated with RCC. It is related to several biochemical abnormalities and production of cytokines by the tumor.
Case Presentation: We present a 44 years old male patient with left renal and adrenal mass, who had isolated elevation of liver enzymes. Patient underwent robotic radical nephrectomy converted to open radical nephrectomy with left adrenalectomy with complete resolution of syndrome features.
Conclusion: Stauffer’s syndrome should be kept in mind when patient having hepatic dysfunction with or without jaundice with confirmed or suspicious renal mass presents to clinicians after ruling out all other etiologies.
References
- Boxer RJ, Waisman J, Lieber MM, Mampaso FM, Skinner DJ. Non metastatic hepatic dysfunction associated with renal carcinoma. J Urol. 1978;119(4):468-71.
- Sharma N, Darr U, Sood G. Stauffer syndrome: a comprehensive review of the icteric variant of the syndrome. Cureus. 2019;11(10):6032.
- Stauffer MH: Nephrogenic Hepatosplenomegaly. Gastroenterology 1961;40:694-96.
- Gold PJ, Fefer A, Thompson JA. Paraneoplastic manifestations of renal cell carcinoma. Semin Urol Oncol.1996; 14(4):216-22.
- Boxer RJ, Waisman J, Lieber MM, Mampaso FM, Skinner DJ. Non metastatic hepatic dysfunction associated with renal carcinoma. J Urol. 1978;119(4):468-71.
- Blay JY, Rossi JF, Wijdenes J, et al. Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal cell carcinoma. Int J Cncer 1997;72(3):424-30.
- Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J SurgPathol 1982;6:655-63.
- Fontes-Sousa M, Magalhaes H, da Silva FC, Mauricio MJ. Stauffer’s syndrome: a comprehensive review and proposed updated diagnostic criteria. Urol Oncol Semin Orig Investig. 2018;36(7):321-26.
- Dourakis SP, Sinai C, Deutsch M, Dimitriadou E, Hadziyannis SJ. Cholestatic jaundice as a paraneoplastic manifestation of renal cell carcinoma. Eur J GastroenterolHepatol 1997;9:311-314.
- Giannakos G, Papanicolaou X, Trafalis D, Michaelidis I, Margaritis G, Christofilakis C. Stuffer’s syndrome variant associated with renal cell carcinoma. Int J Urol 2005;12:757-59.
- Karakolios A, Kasapis C, Kallinikidis T, et al. Cholestatic jaundice as a paraneoplastic manifestation of prostate adenocarcinoma. Clin Gastroenterol Hepatol. 2003;1(6): 480-83.